News
FDA approves Johnson & Johnson's nasal spray for depression as standalone treatment By Annika Kim Constantino,CNBC • Published January 21, 2025 • Updated on January 21, 2025 at 11:04 am BOOKMARKER ...
The U.S. Food and Drug Administration has approved a ketamine-derivative nasal spray to treat depression. The medication is called eskatamine and it's developed by Johnson & Johnson subsidiary ...
The Food and Drug Administration on Tuesday approved Johnson & Johnson's nasal spray to be used alone in adults with a major depressive disorder that is difficult to treat, as sales of the drug ...
The Food and Drug Administration approved Johnson & Johnson's nasal spray to be used alone in adults with a major depressive disorder that is difficult to treat, as sales of the drug grow. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results